Knowledge Center

Article / Aug 30, 2016

Accelerating approval and reducing costs of spray dried drugs through development by design

Authors:
  • Filipe Gaspar
  • Marcio Temtem
Source:
Pharma's Almanac, Global Pharmaceutical Supply Chain Trends, Q3 2016

Contract development and manufacturing organizations with unique technical capabilities and expertise are able to speed up the development and commercialization of novel medicines. Effective application of its extensive knowledge, data base and Development by Design approach has enabled ËÄÉ«AV to accelerate spray drying development, simultaneously reducing cost and time to get challenging drugs to patients in need.

Related links

Also in the Knowledge Center

Related Content

Capabilities

Providing support for all stages of development and production.

Page
Read more

ËÄÉ«AV and Zerion Pharma create joint venture to further expand use of Dispersome® technology

Press Release / Oct 03, 2024
Article
View

Drug Product Development

Leveraging our expertise particle engineering, ËÄÉ«AV can now develop oral dosage forms and inhaled dosages forms to offer dependable solutions for complex drug products.

Page
Read more